About ev3 Endovascular
ev3 Endovascular is a company based in Plymouth (United States) founded in 2000 was acquired by Covidien in June 2010.. ev3 Endovascular has raised $58.8 million across 1 funding round from investors including Warburg Pincus, Covidien and The Vertical Group. The company has 1,307 employees as of December 31, 2009. ev3 Endovascular has completed 3 acquisitions, including Chestnut Medical, EndiCor Medical and FoxHollow Technologies. ev3 Endovascular operates in a competitive market with competitors including Contego Medical, Echopoint Medical, Limflow, AngioScore and Vascular Solutions, among others.
- Headquarter Plymouth, United States
- Employees 1307 as on 31 Dec, 2009
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ev3 Endovascular, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$58.8 M (USD)
in 1 rounds
-
Latest Funding Round
$58.8 M (USD), Series A
Jun 01, 2002
-
Investors
Warburg Pincus
& 2 more
-
Employee Count
1307
as on Dec 31, 2009
-
Investments & Acquisitions
Chestnut Medical
& 2 more
-
Acquired by
Covidien
(Jun 01, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ev3 Endovascular
ev3 Endovascular has successfully raised a total of $58.8M through 1 strategic funding round. The most recent funding activity was a Series A round of $58.8 million completed in June 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $58.8M
-
First Round
First Round
(01 Jun 2002)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2002 | Amount | Series A - ev3 Endovascular | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ev3 Endovascular
ev3 Endovascular has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Warburg Pincus, Covidien and The Vertical Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in early and late-stage US companies are made.
|
Founded Year | Domain | Location | |
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Medical devices for minimally invasive therapies are provided globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ev3 Endovascular
ev3 Endovascular has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Chestnut Medical, EndiCor Medical and FoxHollow Technologies. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Minimally invasive therapies for interventional neuroradiology are developed and provided.
|
2003 | ||||
|
Medical devices for the treatment of coronary and peripheral arterial disease
|
1996 | ||||
|
Medical devices for cardiovascular treatments are developed.
|
1995 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - ev3 Endovascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ev3 Endovascular Comparisons
Competitors of ev3 Endovascular
ev3 Endovascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Contego Medical, Echopoint Medical, Limflow, AngioScore and Vascular Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| domain | founded_year | HQ Location |
Smart devices for monitoring coronary artery disease are developed.
|
|
| domain | founded_year | HQ Location |
Developer a system for venous arterialization of the lower limbs
|
|
| domain | founded_year | HQ Location |
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
|
|
| domain | founded_year | HQ Location |
Products for vascular diagnostics and interventional procedures are developed.
|
|
| domain | founded_year | HQ Location |
Devices for treating peripheral and coronary vascular disease are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ev3 Endovascular
Frequently Asked Questions about ev3 Endovascular
When was ev3 Endovascular founded?
ev3 Endovascular was founded in 2000 and raised its 1st funding round 2 years after it was founded.
Where is ev3 Endovascular located?
ev3 Endovascular is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Who is the current CEO of ev3 Endovascular?
Bob Palmisano is the current CEO of ev3 Endovascular.
Is ev3 Endovascular a funded company?
ev3 Endovascular is a funded company, having raised a total of $58.8M across 1 funding round to date. The company's 1st funding round was a Series A of $58.8M, raised on Jun 01, 2002.
How many employees does ev3 Endovascular have?
As of Dec 31, 2009, the latest employee count at ev3 Endovascular is 1,307.
What does ev3 Endovascular do?
ev3 Endovascular (previously known as Vertomed) develops, manufactures, and commercializes equipment, technologies, and solutions for the treatment of peripheral vascular and neurovascular diseases. Its products include plaque excision systems, stents, carotid stents, percutaneous transluminal angioplasty balloons, embolic protection devices, thrombus management systems, blood clot therapy products, procedural support products, embolization coils, liquid embolics, micro catheters, thrombectomy catheters, occlusion balloons, guidewires, and retrieval devices. The company sells more than 100 products in more than 65 countries through a direct sales team and distributors. Among its customers are radiologists, cardiologists, neurosurgeons, and vascular surgeons. The company sells its products in Asia Pacific, Latin America, Eastern Europe, and the Middle East. eV3 endovascular was acquired by Covidien in 2010 for 2.6 Billion. Before beinmg acquired by Covidien, eV3 had acquired Endicor Medical, Microvena, Mitralife, Appriva Medical, Intratherapeutics.
Who are the top competitors of ev3 Endovascular?
ev3 Endovascular's top competitors include Contego Medical, Limflow and Shape Memory Medical.
How many acquisitions has ev3 Endovascular made?
ev3 Endovascular has made 3 acquisitions, including Chestnut Medical, EndiCor Medical, and FoxHollow Technologies.
Who are ev3 Endovascular's investors?
ev3 Endovascular has 3 investors. Key investors include Warburg Pincus, Covidien, and The Vertical Group.